{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:59:17Z","timestamp":1780336757749,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s13760-019-01133-3","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T08:03:37Z","timestamp":1554710617000},"page":"555-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Early predictors of functional disability in Guillain\u2013Barr\u00e9 Syndrome"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9747-5285","authenticated-orcid":false,"given":"Abdulkadir","family":"Tun\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"8","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Berg Van den","year":"2014","unstructured":"Van den Berg B, Walgaard C, Drenthen J et al (2014) Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469\u2013482","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1590\/0004-282X20160132","volume":"74","author":"HH Ozdemir","year":"2016","unstructured":"Ozdemir HH (2016) Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain\u2013Barr\u00e9 syndrome. Arq Neuropsiquiatr 74(9):718\u2013722","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"1133_CR3","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.4081\/ni.2017.7032","volume":"9","author":"S Sahin","year":"2017","unstructured":"Sahin S, Cinar N, Karsidag S (2017) Are cerebrospinal fluid protein levels and plasma neutrophil\/lymphocyte ratio associated with prognosis of Guillain Barr\u00e9 syndrome? Neurol Int 9(2):7032","journal-title":"Neurol Int"},{"issue":"2","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/CND.0000000000000091","volume":"17","author":"DB DiCapua","year":"2015","unstructured":"DiCapua DB, Lakraj AA, Nowak RJ et al (2015) Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain\u2013Barr\u00e9 syndrome. J Clin Neuromuscul Dis 17(2):47\u201351","journal-title":"J Clin Neuromuscul Dis"},{"key":"1133_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J et al (2014) Diagnosis of Guillain\u2013Barr\u00b4e syndrome and validation of Brighton criteria. Brain 137:33\u201343","journal-title":"Brain"},{"key":"1133_CR6","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain\u2013Barr\u00b4e syndrome. N Engl J Med 366:2294\u20132304","journal-title":"N Engl J Med"},{"issue":"7","key":"1133_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry 83(7):711\u2013718","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1133_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain\u2013Barre syndrome. Neurology 76:968\u2013975","journal-title":"Neurology"},{"issue":"1\u20132","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jns.2013.09.002","volume":"335","author":"R Verma","year":"2013","unstructured":"Verma R, Chaudhari TS, Raut TP et al (2013) Clinico-electrophysiological profile and predictors of functional outcome in Guillain\u2013Barre syndrome (GBS). J Neurol Sci 335(1\u20132):105\u2013111","journal-title":"J Neurol Sci"},{"issue":"1","key":"1133_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0377-4929.130897","volume":"57","author":"C Vaishnavi","year":"2014","unstructured":"Vaishnavi C, Kapoor P, Behura C et al (2014) C-reactive protein in patients with Guillain Barr\u00e9 syndrome. Indian J Pathol Microbiol 57(1):51\u201354","journal-title":"Indian J Pathol Microbiol"},{"issue":"4","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/00207454.2016.1163551","volume":"127","author":"JO Sipil\u00e4","year":"2017","unstructured":"Sipil\u00e4 JO, Kauko T, Soilu-H\u00e4nninen M (2017) Admission sodium level and prognosis in adult Guillain\u2013Barr\u00e9 syndrome. Int J Neurosci 127(4):344\u2013349","journal-title":"Int J Neurosci"},{"issue":"10","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/00207454.2016.1278541","volume":"127","author":"Y Huang","year":"2017","unstructured":"Huang Y, Ying Z, Chen Z et al (2017) Thyroid hormone level is associated with the frequency and severity of Guillain\u2013Barr\u00e9 syndrome. Int J Neurosci 127(10):893\u2013899","journal-title":"Int J Neurosci"},{"key":"1133_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome. Ann Neurol 27:21\u201324","journal-title":"Ann Neurol"},{"issue":"8093","key":"1133_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD et al (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2(8093):750\u2013753","journal-title":"Lancet"},{"issue":"5","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA et al (1998) Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome. Plasma exchange\/sandoglobulin Guillain\u2013Barr\u00e9 syndrome trial group. Ann Neurol 44(5): 780\u2013788","journal-title":"Ann Neurol"},{"key":"1133_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393\u2013407","journal-title":"Nat Rev Immunol"},{"key":"1133_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/0028-3886.53282","volume":"57","author":"A Gonzalez-Quevedo","year":"2009","unstructured":"Gonzalez-Quevedo A, Carriera RF, O\u2019Farrill ZL et al (2009) An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain\u2013Barr\u00e9 syndrome. Neurol India 57:288\u2013294","journal-title":"Neurol India"},{"key":"1133_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-0097-x","volume":"256","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Petzold A, S\u00fcssmuth S et al (2009) Cerebrospinal fluid biomarkers in Guillain\u2013Barr\u00e9 syndrome\u2014where do we stand? J Neurol 256:3\u201312","journal-title":"J Neurol"},{"issue":"1\u20132","key":"1133_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2014.02.019","volume":"340","author":"A Kerasnoudis","year":"2014","unstructured":"Kerasnoudis A, Pitarokoili K, Behrendt V et al (2014) Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain\u2013Barr\u00e9 syndrome. J Neurol Sci 340(1\u20132):37\u201343","journal-title":"J Neurol Sci"},{"key":"1133_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/00207451003695690","volume":"120","author":"M Ghabaee","year":"2010","unstructured":"Ghabaee M, Jabedari B, Al-E-Eshagh N et al (2010) Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain\u2013Barre syndrome and multiple sclerosis patients. Int J Neurosci 120:301\u2013304","journal-title":"Int J Neurosci"},{"key":"1133_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251:261\u2013268","journal-title":"J Neurol"},{"key":"1133_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00726-009-0350-8","volume":"38","author":"D Giuseppe Di","year":"2010","unstructured":"Di Giuseppe D, Ulivelli M, Bartalini S et al (2010) Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids 38:1461\u20131471","journal-title":"Amino Acids"},{"issue":"15","key":"1133_CR23","doi-asserted-by":"publisher","first-page":"e6618","DOI":"10.1097\/MD.0000000000006618","volume":"96","author":"Z Su","year":"2017","unstructured":"Su Z, Chen Z, Xiang Y et al (2017) Low serum levels of uric acid and albumin in patients with Guillain\u2013Barre syndrome. Medicine (Baltimore) 96(15):e6618","journal-title":"Medicine (Baltimore)"},{"key":"1133_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1212\/WNL.0b013e31820d8b40","volume":"76","author":"K Saifudheen","year":"2011","unstructured":"Saifudheen K, Jose J, Gafoor VA et al (2011) Guillain\u2013Barr\u00b4 e syndrome and SIADH. Neurology 76:701\u2013704","journal-title":"Neurology"},{"key":"1133_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1179\/1743132814Y.0000000455","volume":"37","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu J (2015) Hyponatremia is a predictor for poor outcome in Guillain\u2013Barr\u00b4e syndrome. Neurol Res 37:347\u2013351","journal-title":"Neurol Res"},{"key":"1133_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/ane.12459","volume":"133","author":"FL Hiew","year":"2016","unstructured":"Hiew FL, Winer JB, Rajabally YA (2016) Hyponatraemia in Guillain\u2013Barre\u2019 syndrome revisited. Acta Neurol Scand 133:295\u2013301","journal-title":"Acta Neurol Scand"},{"key":"1133_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.54.3.620","volume":"54","author":"R Koningsveld van","year":"2000","unstructured":"van Koningsveld R, van Doorn PA, Schmitz PI et al (2000) Mild forms of Guillain\u2013Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620\u2013625","journal-title":"Neurology"},{"key":"1133_CR28","doi-asserted-by":"publisher","first-page":"968e75","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain\u2013Barre \u00b4 syndrome. Neurology 76: 968e75","journal-title":"Neurology"},{"issue":"6","key":"1133_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.clineuro.2004.12.019","volume":"107","author":"T Seta","year":"2005","unstructured":"Seta T, Nagayama H, Katsura K et al (2005) Factors influencing outcome in Guillain\u2013Barr\u00e9 Syndrome: comparison of plasma adsorption against other treatments. Clin Neurol Neurosurg 107(6):491\u2013496","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"1133_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.kjms.2015.10.010","volume":"31","author":"S Alan","year":"2015","unstructured":"Alan S, Tuna S, T\u00fcrko\u011flu EB (2015) The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Beh\u00e7et\u2019s syndrome. Kaohsiung J Med Sci 31(12):626\u2013631","journal-title":"Kaohsiung J Med Sci"},{"issue":"7","key":"1133_CR31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<846::AID-MUS9>3.0.CO;2-7","volume":"20","author":"J Berciano","year":"1997","unstructured":"Berciano J, Figols J, Garc\u00eda A et al (1997) Fulminant Guillain\u2013Barr\u00e9 syndrome with universal inexcitability of peripheral nerves: a clinicopathological study. Muscle Nerve 20(7):846\u2013857","journal-title":"Muscle Nerve"},{"key":"1133_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/CC11347","volume":"16","author":"SM Lobo","year":"2012","unstructured":"Lobo SM (2012) Sequential C-reactive protein measurements in patients with serious infections: does it help? Crit Care 16:130","journal-title":"Crit Care"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01133-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-019-01133-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01133-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T23:38:30Z","timestamp":1586216310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-019-01133-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s13760-019-01133-3","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}